Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), sold 33,853 shares at $5.00 ($169K) on 2012-08-17, disclosed to the SEC on 2012-08-21.
Scheduled sale ($169k) by CEO & Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-24 | $7K | — | Filing → |
| PSTI | BUY | 2016-02-17 | $16K | — | Filing → |